Ryan Davis

New York

Co-Host and Co-Producer at Out Of Office: A Travel Podcast

Cofounder https://t.co/8akEJVhZeb + https://t.co/OV3O7WzN02. Cohost https://t.co/nkPh7gLgSi & @CJR's Red Pen. Former: @bluestate, Dean For America '04, Theatre Director ('01 - '10)

Articles

Fed. Circ. Faults Ax Of Patent Targeted By Nintendo, Others

1 week ago | law360.co.uk | Ryan Davis

Hello! I'm Law360's automated support bot. How can I help you today? For example, you can type: I forgot my password I took a free trial but didn't get a verification email How do I sign up for a newsletter?
Full Fed. Circ. Undoes $20M Google Loss, Orders New Trial

1 month ago | law360.co.uk | Ryan Davis

Hello! I'm Law360's automated support bot. How can I help you today? For example, you can type: I forgot my password I took a free trial but didn't get a verification email How do I sign up for a newsletter?
Full Fed. Circ. Undoes $20M Google Loss, Orders New Trial

1 month ago | law360.co.uk | Ryan Davis

Hello! I'm Law360's automated support bot. How can I help you today? For example, you can type: I forgot my password I took a free trial but didn't get a verification email How do I sign up for a newsletter?
Justices Skip Recusal Case Over Fitbit Judge's Google Ties

1 month ago | law360.co.uk | Ryan Davis

ADVERTISEMENT Don't want ads? Subscribe or login now. By Ryan Davis ( May 5, 2025, 9:44 AM EDT) -- The U.S. Supreme Court on Monday declined to consider a patent owner's argument that a California federal judge should have recused herself from an infringement suit against Fitbit due to her alleged financial ties to the wearable tech company's parent Google....
Full Fed. Circ. Urged To Undo 'Onerous' Jepson Claim Ruling

1 month ago | law360.co.uk | Ryan Davis

ADVERTISEMENT Don't want ads? Subscribe or login now. By Ryan Davis ( April 29, 2025, 6:08 PM EDT) -- Xencor has urged the full Federal Circuit to review a decision rejecting its application for an antibody patent that used the so-called Jepson claim format, saying the case set an "onerous requirement" that is nearly impossible to meet and "eliminates any incentive" to use the format....
USPTO Director To Take Lead In Considering PTAB Denials

Mar 26, 2025 | law360.co.uk | Ryan Davis

By Ryan Davis ( March 26, 2025, 8:57 PM EDT) -- Citing the Patent Trial and Appeal Board's "workload needs," the acting director of the U.S. Patent and Trademark Office announced Wednesday that she will make decisions on whether every petition challenging a patent should be denied for discretionary reasons before the board considers the merits....
European Stocks Suffer as EU Tarrifs Loom, But FTSE 100 Ticks Higher Amid Trump Talks

Feb 28, 2025 | valuewalk.com | Sam Alberti |Ryan Davis |Carlos De Lanuza |Dave Kovaleski

The UK and U.S. moved one step closer to a tariff-free trade agreement Friday saw mixed fortunes for share prices in Europe, with EU stocks slumping as the prospect of U.S.-imposed tariffs lingers, while the FTSE 100 saw gains on the back of seemingly positive White House talks between Kier Starmer and Donald Trump.
Fed. Circ. Revives Patent Suit Against Groupon

Feb 11, 2025 | law360.co.uk | Ryan Davis

Hello! I'm Law360's automated support bot. How can I help you today? For example, you can type: I forgot my password I took a free trial but didn't get a verification email How do I sign up for a newsletter?
Fed. Circ. Pushes Back At Doctors Who Vouched For Newman

Feb 7, 2025 | law360.co.uk | Ryan Davis

Hello! I'm Law360's automated support bot. How can I help you today? For example, you can type: I forgot my password I took a free trial but didn't get a verification email How do I sign up for a newsletter?
Cedarhurst Senior Living Becomes National Team for 2025

Jan 28, 2025 | globenewswire.com | Ryan Davis

ST. LOUIS, MO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Cedarhurst Senior Living proudly announces its designation as a National Team for the Alzheimer’s Association Walk to End Alzheimer’s® in 2025, marking a significant milestone in the organization’s ongoing commitment to Alzheimer’s advocacy. This recognition highlights Cedarhurst’s leadership in supporting Alzheimer’s research, education, and care.